Immune thrombocytopenia: Difference between revisions

From The School of Biomedical Sciences Wiki
Jump to navigation Jump to search
No edit summary
Nnjm2 (talk | contribs)
Cleaned up the references. Removed some stray code.
 
(8 intermediate revisions by 4 users not shown)
Line 1: Line 1:
Immune Thrombocytopenia (ITP)&nbsp;is a disease in which your immune system&nbsp;destroys the platelets in your blood believing them to be a foreign pathogen that is invading your body. It can occur both in childhood and adulthood of which there is different courses of treatments depending on the severity of the disease.<ref name="1">Kühne T (2016) Hämostaseologie: Diagnosis and management of immune thrombocytopenia in childhood</ref> <references />
Immune Thrombocytopenia (ITP) is a disease in which your [[Immune system|immune system]] destroys the [[Platelets|platelets]] in your [[Blood|blood]] believing them to be a foreign [[Pathogen|pathogen]] that is invading your body. It can occur during any time of a person's life with there being both childhood and adulthood forms, however, as the disease itself is not very common then it makes researching and understanding the disease harder with the cost of funding this type of research being high. There are treatments for this [[Disease|disease]] especially for the childhood form however as Kühne (2016) says "Treatment endpoints differ in clinical research and in clinical practice" making it harder to settle on one direct course of treatment<ref>Kühne T(2016)Hämostaseologie: Diagnosis and management of immune thrombocytopenia in childhood</ref>.
 
=== References  ===
 
<references />

Latest revision as of 08:44, 5 December 2017

Immune Thrombocytopenia (ITP) is a disease in which your immune system destroys the platelets in your blood believing them to be a foreign pathogen that is invading your body. It can occur during any time of a person's life with there being both childhood and adulthood forms, however, as the disease itself is not very common then it makes researching and understanding the disease harder with the cost of funding this type of research being high. There are treatments for this disease especially for the childhood form however as Kühne (2016) says "Treatment endpoints differ in clinical research and in clinical practice" making it harder to settle on one direct course of treatment[1].

References

  1. Kühne T(2016)Hämostaseologie: Diagnosis and management of immune thrombocytopenia in childhood